Today, our CEO Meta Roestenberg was live on BNR Zakendoen!
In the interview, she outlined INFECTA’s approach: to accelerate the development of vaccines and therapeutics for infectious diseases through cutting-edge early-phase clinical trials.
She also invited donors and partners to join us in making this mission a reality: advancing innovation in infectious-disease research together.
Listen to the interview via the link: https://www.bnr.nl/podcast/zakendoen/10585974/marcel-beerthuizen-ziggo-sport-over-de-competitieve-sportrechtenmarkt